Effective January 1, 2015, Novolin, Novolog, Lantus and Levemir will be the insulin products with preferred status for Commercial and Exchange Market formularies.

This week's Generic News includes information on OneStop program enhancements from McKesson, generic launches of Focalin and Cyclophosphamide, and much more.

Effective immediately, over-the-counter (OTC) medications in the state of Florida will not require a prescription for successful claims adjudication for Amerigroup Medicaid members.

Inside this issue:

Generic drugs have been in the news quite a bit this week, thanks to unprecedented price increases. We've collected a few of the most interesting links in one place for your review.